WONDFO BIOTECH(SZ:300482) Sou Hu Cai Jing·2025-08-19 23:48Core Insights - Wanfu Biological (300482.SZ) released its semi-annual report for 2025, indicating a total of 9 institutional investors holding shares, amounting to 86.39 million shares, which represents 17.95% of the total share capital [1][2] - The proportion of shares held by institutional investors increased by 1.10 percentage points compared to the previous quarter [1] - One public fund, Donghai Social Security, increased its holdings, while another, Huabao CSI Medical ETF, saw a slight decrease in holdings [1] Institutional Holdings - The institutional investors include notable entities such as Guangzhou Huiyin Tianyue Equity Investment Fund Management Co., Bank of China - Huabao CSI Medical ETF, and Hong Kong Central Clearing Limited [1] - The total institutional holding percentage stands at 17.95%, reflecting a growing interest from institutional investors [1] Public Fund Activity - One new public fund disclosed its holdings, which is the Southern CSI 1000 ETF, while two public funds, Haifutong Xinrui Mixed A and Haifutong Xinying 6-Month Holding Period Mixed A, were not disclosed in the current period [1] - The overall activity among public funds indicates a mixed sentiment, with one fund increasing and another decreasing its holdings [1] Social Security Fund and Foreign Investment - The National Social Security Fund 118 Combination is the only new social security fund disclosed as holding shares in Wanfu Biological [2] - One foreign institution, Hong Kong Central Clearing Limited, has also newly disclosed its holdings in the company [2]